Welcome and thanks for reading!
In this review, I
will make a summary of important and interesting news and events over
the last week related to my portfolio holdings. Also, I will put
together some interesting articles from other websites that caught my
attention during the past week.
Received
Dividends:
October 6, 2025
€93.49 –
Canadian Natural Resources Limited (CNQ)
October 7, 2025
€44.24 – JPM
Global Equity Premium Income Active UCITS ETF (JGPI.DE)€14.70 – JPM
US Equity Premium Income Active UCITS ETF (JEIP.DE)€39.84 – JPM
Nasdaq Equity Premium Income Active UCITS ETF (JEQP.DE)
October 9, 2025
€24.26 – Best
Buy Co., Inc. (BBY)
October 10, 2025
€22.93 – Global
X SuperDividend™ ETF (SDIV)
Week 41: Total net
dividends €239.46
Dividend
income is reported after the deduction of taxes. Check more at my
Monthly
Dividend
sheet.
My Portfolio’s
Transactions:
October 6, 2025
I purchased 51
shares of JPM Nasdaq Equity Premium Income Active UCITS ETF (JEQP.DE)
at €22.325 per share plus commission.
Based on the
latest announcement,
JEQP will pay a dividend of $0.1755 per share for October. Over the
past 11th months, JEQP has declared a total dividend of $2.2206 per
share. If the current level continues, this would imply an annualized
dividend of $2.4225 per share.
At today’s
exchange rate, my purchase of 51 shares of JEQP will increase my
expected annual net dividend income by €74.14. Following this
acquisition, my yield on cost stands at 10.93%, with JEQP now
representing approximately 1.26% of my portfolio and accounting for
about 2.65% of my future annual dividend income.
For the time
being, my strategy is to continue building my JEQP position gradually
through monthly purchases.
Portfolio Holdings
News:
October 6, 2025
Amgen
Inc. (AMGN) makes Repatha available through ‘AmgenNow’ direct to
patient program; AMGN announced that it has launched its
cholesterol medication, Repatha, directly to consumers in the U.S. at
a reduced cash price. In support of the Trump Administration’s
efforts to lower drug prices for Americans, Repatha will be available
through AmgenNow at a monthly price of $239, nearly 60% lower than
the current U.S. list price.
Pembina
Pipeline Corporation (TSE:PPL) Provides Update on Greenlight
Electricity Centre; PPL and its partner Kineticor said Monday
they are making progress on the proposed Greenlight Electricity
Centre, a multi-phased gas-fired combined cycle power generation
facility in Alberta, with a capacity of as much as 1,800 MW.
October 7, 2025
NCC
AB (NCC) initiates preparatory groundwork for LKAB in Gällivare,
Sweden; NCC has been commissioned by LKAB to begin preparatory
groundwork ahead of the construction of a new sorting plant at LKAB’s
facility in Vitåfors, Gällivare. The order value amounts to
approximately SEK 200 million.
October 8, 2025
NCC
AB (NCC) to construct new hospital building in Oulu, Finland; NCC
has been commissioned by the Northern Ostrobothnia Hospital District
to construct Building C at the Oulu University Hospital in Finland.
The order value is just over SEK 1.7 billion.
NCC
AB (NCC) to build new parking facility in southern Stockholm; NCC
has been commissioned to construct a new parking facility for
Stockholm Stads Parkerings AB in the Slakthusområdet area, southern
Stockholm. The project, Sandhagsgatan P-hus, will be carried out as a
turnkey contract in collaboration and has an order value of
approximately SEK 200 million.
Verizon
Communications Inc. (VZ) accelerates fixed wireless broadband
expansion with acquisition of Starry; VZ announced a definitive
agreement to acquire Starry, a leading provider of next-generation
fixed wireless broadband services. This strategic acquisition
advances Verizon’s differentiated ability to deliver high-speed
internet to multi-dwelling units (MDUs) and urban communities,
leveraging Starry’s innovative millimeter wave technology. The
acquisition is expected to close by the first quarter of 2026.
October 9, 2025
PepsiCo,
Inc. (PEP) Reports Third-Quarter 2025 Results; PEP reported
second-quarter Non-GAAP EPS of $2.29, a 2.0% decline compared to the
same period last year, but $0.03 above analyst expectations. Revenue
grew by 2.7% year-over-year to $23.94 billion, beating estimates by
$90 million. For full-year 2025, management maintains its outlook,
expecting a low-single-digit increase in organic revenue and core
constant currency EPS to remain roughly flat compared to the prior
year.
October 10, 2025
Bristol-Myers
Squibb Company (BMY) Strengthens and Diversifies Cell Therapy
Portfolio with Acquisition of Orbital Therapeutics; BMY has
agreed to acquire privately held biotechnology company Orbital
Therapeutics for $1.5 billion in cash. Orbital Therapeutics is
advancing a new generation of RNA medicines designed to reprogram
cells in vivo, treating diseases at their source. Its lead RNA
immunotherapy preclinical candidate, OTX-201, targets autoimmune
disease through B cell depletion to reset the immune system.
Lockheed
Martin Corporation (LMT) Announces Dividend Increase; LMT board
of directors has authorized a fourth quarter 2025 dividend of $3.45
per share. This is an increase of $0.15, or 5%, per share over the
last quarter and represents the company’s 23rd consecutive year of
dividend increases. The dividend is payable on Dec. 30, 2025, to
holders of record as of the close of business on Dec. 1, 2025. LMT’s
board has also authorized the purchase of up to an additional $2
billion of Lockheed Martin common stock under its share repurchase
program. With this increase, total authorization for future
repurchases under the share repurchase program is approximately $9.1
billion.
T.
Rowe Price Group, Inc. (TROW) Reports Preliminary Month-End Assets
Under Management For September 2025; TROW announced preliminary
September month-end assets under management of $1.77 trillion.
Preliminary net outflows for September 2025 were $2.0 billion. For
the quarter-ended September 2025, net outflows were $7.9 billion,
including $0.8 billion of manager-driven distributions.
Articles that
caught my attention:
Undervalued
Dividend Growth Stock of the Week: A. O. Smith (AOS) by Jason
Fieber at Daily Trade AlertCalling
the bottom on Canadian telco stocks, on the Sunday Reads by Dale
Roberts at Cut the Crap InvestingDividends
Matter (A Lot) by Dividend Growth InvestorMy
Top 10 High-Yield Dividend Stocks For October 2025: One Yields
11%-Plus by Frederik Mueller at Seeking Alpha10
Consistent Dividend Stocks For Long-Term Income by Bob Ciura at
Sure DividendThis
Blue-Chip Giant’s Stock Is in the Gutter – Buy of the Decade?
by Dan Kent at Stocktrades CanadaCummins:
Watch This Dividend Aristocrat In The Making Now by Kody’s
Dividends at Seeking AlphaBristol-Myers
Squibb: Your Chance To Buy A Bargain 6% Yield by Jonathan Weber
at Seeking AlphaHormel
Foods Corp. (HRL) Dividend Stock Analysis by D4L at Dividend
Growth StocksLow
Debt Companies to Invest In by Mike at The Dividend Guy BlogIf
I Could Buy Just 3 High-Yield Dividend Stocks Right Now by Leo
Nelissen at Seeking Alpha
Thanks for
stopping by!